Telehealth support for managing ostomies in cancer patients
Official title: Perioperative Ostomy Self-Management Telehealth Intervention for Cancer Survivors
Run by City of Hope Medical Center · NCT06528990 · Data updated 2026-11-12
This study is testing a telehealth program to help people with colorectal and bladder cancer manage their ostomies better before and after surgery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | City of Hope Medical Center Academic / other |
| Locations | 1 site (Duarte, California) |
| Status | Recruiting |
| Started | January 2, 2025 |
| Main results expected | June 4, 2028 |
| Study ends | June 4, 2028 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT06528990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with bladder or colorectal cancer who are scheduled for surgery involving the creation of an intestinal stoma.
✕Probably not a fit
Patients who do not have bladder or colorectal cancer or those not undergoing ostomy surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot clinical trial aims to evaluate a telehealth intervention designed to assist patients with colorectal and bladder cancer in managing their ostomies. Participants will engage in seven group telehealth sessions before and after their ostomy surgery, focusing on self-management techniques and addressing common challenges faced by ostomy patients. The study will assess the feasibility and preliminary efficacy of this intervention compared to standard care, with the goal of improving health-related quality of life for both patients and their family caregivers.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life for patients with ostomies and their caregivers by providing effective self-management strategies.
How similar studies have gone: While telehealth interventions for chronic conditions have shown promise, this specific approach for ostomy management in cancer patients is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Eligibility Criteria: * Patient with bladder or colorectal cancer * Scheduled to undergo a surgical procedure that includes the creation of an intestinal stoma (fecal or urinary, permanent or temporary) * For bladder cancer, only patients with incontinent urostomies (ileal conduit) are eligible. * Age: ≥ 18 years * Ability to read and understand English for Questionnaires Family Caregiver Eligibility Criteria: * A family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's care before and after surgery * Age: ≥ 18 years * Ability to read and understand English for Questionnaires * Pregnant FCGs are eligible for participation. Participation in this behavioral/educational intervention should not impact the pregnancy/fetus.
Where it's running
-
City of hope Medical Center
Duarte, California, United States Recruiting
Study contacts
- Principal investigator: Virginia Sun, PhD, RN — City of Hope Medical Center
- Study coordinator: Virginia Sun, PhD, RN
- Email: vsun@coh.org
- Phone: 626-218-3122
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EBNK-001 allogeneic NK cell therapy with low-dose IL-15, with or without pembrolizumab, for advanced solid tumors
This treatment tests an off-the-shelf NK cell product (EBNK-001) given with low-dose IL-15, either alone or with pembrolizumab, in adults with advanced or metastatic solid tumors who have exhausted standard options.
-
SL-28 for Advanced Solid Tumours
A new allogeneic cell therapy called SL-28 is being tested in adults with advanced solid tumors to see if it is safe and can help shrink tumors.
-
Predicting Immunotherapy Response from Live Tumor Biopsies
This project will try to see if analyzing live tumor biopsy samples kept in their 3D environment can predict whether people with advanced solid tumors will respond to immunotherapy.
-
Timing smartphone messages to boost activity for older cancer survivors with chronic pain
This study tests whether sending short smartphone messages at certain times can increase physical activity in older cancer survivors with chronic pain.
-
IDOV-Immune for advanced solid tumors
This trial will try a single IV infusion of an engineered oncolytic vaccinia virus called IDOV-Immune in adults with advanced solid tumors that no longer respond to standard treatments.
-
Precision oncology navigation with expert genomic review to guide therapy and survival
This tests whether a centralized precision oncology navigator and expert review of NGS results increase the use of genome-informed therapies for people with stage IV breast, lung, colorectal, or bladder cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.